The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
ESAT-6 Subunit Vaccination against Mycobacterium tuberculosis
Open accessAbstract
The ESAT-6 antigen from Mycobacterium tuberculosis is a dominant target for cell-mediated immunity in the early phase of tuberculosis (TB) in TB patients as well as in various animal models. The purpose of our study was to evaluate the potential of ESAT-6 in an experimental TB vaccine. We started out using dimethyl dioctadecylammonium bromide (DDA), an adjuvant which has been demonstrated to be efficient for the induction of cellular immune responses and has been used successfully before as a delivery system for TB vaccines. Here we demonstrate that, whereas immune responses to both short-term-culture filtrate and Ag85B are efficiently induced with DDA, this adjuvant was inefficient for the induction of immune responses to ESAT-6. Therefore, we investigated the modulatory effect of monophosphoryl lipid A (MPL), an immunomodulator which in different combinations has demonstrated strong adjuvant activity for both cellular and humoral immune responses. We show in the present study that vaccination with ESAT-6 delivered in a combination of MPL and DDA elicited a strong ESAT-6-specific T-cell response and protective immunity comparable to that achieved with Mycobacterium bovis BCG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Variation in protection by BCG: implications of and for heterologous immunity
Fine, P. E. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92348-9 · Cited by 1,380
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870 · cited 2×
“Of relevance in this context, MPL is very hydrophobic and has in fact worked most efficiently together with lipid-containing delivery vehicles such as squalenein-water emulsions (13), liposomes (1), or surface-active adjuvants like QS21 (39).”
BackgroundImmunogenicity and protective efficacy of a tuberculosis DNA vaccine
Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Randall Deck, R., DeWitt, C. M., Orme, I. M., Baldwin, S., D'Souza, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-893 · Cited by 629
Horwitz, M. A., Lee, B. W., Dillon, B. J., & Harth, G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1530 · Cited by 432
T Cell Response to Mycobacterium tuberculosis
Orme, I. M., Andersen, P., & Boom, W. H. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1481 · Cited by 423
Self-citationAndersen, P. (1994) · Infection and Immunity · doi:10.1128/iai.62.6.2536-2544.1994 · Cited by 416
Self-citationProteins released from Mycobacterium tuberculosis during growth
Andersen, P., Askgaard, D., Ljungqvist, L., Bennedsen, J., & Heron, I. (1991) · Infection and Immunity · doi:10.1128/iai.59.6.1905-1910.1991 · Cited by 305
Self-citationMonophosphoryl lipid A as an adjuvant. Past experiences and new directions.
Ulrich, J. T., & Myers, K. R. (1995) · PubMed · Cited by 301
Kamath, A. T., Feng, C. G., Macdonald, M., Briscoe, H., & Britton, W. J. (1999) · Infection and Immunity · doi:10.1128/.67.4.1702-1707.1999 · Cited by 301
Human T Cell Responses to the ESAT‐6 Antigen from Mycobacterium tuberculosis
Ravn, P., Demissie, A., Eguale, T., Wondwosson, H., Lein, D., Amoudy, H. A., Mustafa, A. S., Jensen, A. K., Holm, A., Rosenkrands, I., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314640 · Cited by 301
Self-citationGrun, J. L., & Maurer, P. H. (1989) · Cellular Immunology · doi:10.1016/0008-8749(89)90011-7 · Cited by 281
Evaluation of New Vaccines in the Mouse and Guinea Pig Model of Tuberculosis
Baldwin, S. L., D’Souza, C., Roberts, A. D., Kelly, B. P., Frank, A. A., Lui, M. A., Ulmer, J. B., Huygen, K., McMurray, D. M., & Orme, I. M. (1998) · Infection and Immunity · doi:10.1128/iai.66.6.2951-2959.1998 · Cited by 272
Adjuvant modulation of immune responses to tuberculosis subunit vaccines
Lindblad, E. B., Elhay, M. J., Silva, R., Appelberg, R., & Andersen, P. (1997) · Infection and Immunity · doi:10.1128/iai.65.2.623-629.1997 · Cited by 238
Self-citationPal, P. G., & Horwitz, M. A. (1992) · Infection and Immunity · doi:10.1128/iai.60.11.4781-4792.1992 · Cited by 235
Monophosphoryl Lipid A as an Adjuvant: Past Experiences and New Directions
Ulrich, J. T., & Myers, K. R. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_21 · Cited by 222
Brandt, L., Oettinger, T., Holm, A., Andersen, A. B., & Andersen, P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3527 · Cited by 212
Self-citationPollock, J. M., & Andersen, P. (1997) · The Journal of Infectious Diseases · doi:10.1086/593686 · Cited by 182
Self-citationHost Responses and Antigens Involved in Protective Immunity to Mycobacterium tuberculosis
ANDERSEN, P. (1997) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1997.d01-380.x · Cited by 169
Self-citationLi, Z., Howard, A., Kelley, C., Delogu, G., Collins, F., & Morris, S. (1999) · Infection and Immunity · doi:10.1128/iai.67.9.4780-4786.1999 · Cited by 160
Pollock, J. M., & Andersen, P. L. (1997) · Infection and Immunity · doi:10.1128/iai.65.7.2587-2592.1997 · Cited by 156
Self-citationLipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants
Alving, C. R. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80355-4 · Cited by 152
Astiz, M. E., Rackow, E. C., Still, J., Howell, S. T., Cato, A. E., Eschen, K. B. V., Ulrich, J. T., Rudbach, J. A., McMahon, G., Vargas, R., et al. (1995) · Critical Care Medicine · doi:10.1097/00003246-199501000-00006 · Cited by 129
The theory and practical application of adjuvants
Stewart-Tull, D. E. S. (1995) · Cited by 119
B-Cell Epitopes and Quantification of the ESAT-6 Protein ofMycobacterium tuberculosis
Harboe, M., Malin, A. S., Dockrell, H. S., Wiker, H. G., Ulvund, G., Holm, A., Jørgensen, M. K., & Andersen, P. L. (1998) · Infection and Immunity · doi:10.1128/iai.66.2.717-723.1998 · Cited by 98
Self-citationIdentification of Immunodominant Antigens during Infection with Mycobacterium tuberculosis
Andersen, P. L., Askgaard, D. S., Gottschau, A., et al. (1992) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1992.tb03144.x · Cited by 96
Self-citationProtection against lethal viral infection by vaccination with nonimmunodominant peptides
Oukka, M., Manuguerra, J., Livaditis, N., Tourdot, S., le Riche, N., Vergnon, I., Cordopatis, P., & Kosmatopoulos, K. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.7.3039 · Cited by 81
Is IgG2a a good Thl marker in mice?
Martin, R. M., & Lew, A. M. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)87499-3 · Cited by 78
Masihi, K. N., Lange, W., Brehmer, W., & Ribi, E. E. (1986) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(86)90116-5 · Cited by 71
SINGLE-DOSE ANTENATAL TETANUS IMMUNISATION
Stanfield, J. P., Gall, D., & Bracken, P. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90062-7 · Cited by 71
Diverse CD1d-restricted reactivity patterns of human T cells bearing “invariant” AV24BV11 TCR
Couedel, C., Peyrat, M., Brossay, L., Koezuka, Y., Porcelli, S. A., Davodeau, F., & Bonneville, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199812)28:12<3949::aid-immu3949>3.0.co;2-4 · Cited by 67
Ljungqvist, L., Worsaae, A., & Heron, I. (1988) · Infection and Immunity · doi:10.1128/iai.56.8.1994-1998.1988 · Cited by 58
Worsaae, A., Ljungqvist, L., & Heron, I. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.12.2608-2614.1988 · Cited by 32
Immunological requirements for a subunit vaccine against tuberculosis
Elhay, M. J., & Andersen, P. L. (1997) · Immunology and Cell Biology · doi:10.1038/icb.1997.94 · Cited by 22
Self-citationImmunomodulatory Effects of Bacterial Lipopolysaccharide
Jacobs, D. M. (1981) · Journal of Immunopharmacology · doi:10.3109/08923978109026423 · Cited by 17
Cited by
Pym, A. S., Brodin, P., Brosch, R., Huerre, M., & Cole, S. T. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03237.x · Cited by 729
“However, the results of all immunization studies performed to date indicate that the protection they confer in this formulation is no better than that afforded by BCG (Brandt et al., 2000; Olsen et al., 2000; Louise et al., 2001).”
BackgroundHow can immunology contribute to the control of tuberculosis?
Kaufmann, S. H. E. (2001) · Nature Reviews Immunology · doi:10.1038/35095558 · Cited by 729
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
Pym, A. S., Brodin, P., Majlessi, L., Brosch, R., Demangel, C., Williams, A., Griffiths, K. E., Marchal, G., Leclerc, C., & Cole, S. T. (2003) · Nature Medicine · doi:10.1038/nm859 · Cited by 644
Virulence factors of the Mycobacterium tuberculosis complex
Forrellad, M. A., Klepp, L. I., Gioffré, A., Sabio y García, J., Morbidoni, H. R., Santangelo, M. D. L. P., Cataldi, A. A., & Bigi, F. (2013) · Virulence · doi:10.4161/viru.22329 · Cited by 622
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
Casella, C. R., & Mitchell, T. C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8228-6 · Cited by 560
Metadata
- Authors
- Brandt, L., Elhay, M., Rosenkrands, I., Lindblad, E. B., & Andersen, P.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2000-02
- Volume
- 68
- Issue
- 2
- Pages
- 791-795
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2163964526
- Cited by
- 335
- References
- 34
- FWCI
- 15.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.